Clinical Trials Directory

Trials / Completed

CompletedNCT01599741

X-ray Dose Reduction Study for Endovascular Interventional Radiology

Clinical Validation and Evaluation of X-ray Image Processing for Endovascular Digital Subtraction Angiography and Intervention

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
51 (actual)
Sponsor
Philips Clinical & Medical Affairs Global · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

ClarityIQ is a novel X-ray imaging technology, that combines advanced real-time image noise reduction algorithms, with state-of-the-art hardware to reduce patient entrance dose significantly. This is realized by anatomy-specific optimization of the full acquisition chain (grid switch, beam filtering, pulse width, spot size, detector and image processing engine) for every clinical task individually. Furthermore, smaller focal spot sizes, shorter pulses and the introduction of automatic real-time motion compensation in subtraction imaging are used, which are known to positively influence image quality . The final effect on the clinical image quality in peripheral angiography is investigated in this study.

Detailed description

X-ray dose and image quality are related by laws of physics. Low dose and high image quality cannot be achieved at the same time. However, image processing algorithms can help an x-ray system to acquire images with lower dose without influencing image quality or achieving higher image quality with equal dose. The primary aim of this study is to verify if the diagnostic image quality is equal or better when using a significant reduction in X-ray dose for endovascular digital subtraction angiography in combination with a novel imaging technology compared to using normal dose with conventional image technology.

Conditions

Interventions

TypeNameDescription
RADIATIONLow-dose DSA (83% reduction compared to normal dose) with novel X-ray imaging technology.Digital Subtraction Angiography (DSA) of iliac artery with reduced dose settings (83% dose reduction expected) in combination with novel X-ray imaging technology.
RADIATIONNormal dose DSA with conventional X-ray imaging technologyDigital Subtraction Angiography (DSA) of iliac artery with normal dose settings in combination with conventional X-ray imaging technology.

Timeline

Start date
2012-06-01
Primary completion
2013-05-01
Completion
2013-05-01
First posted
2012-05-16
Last updated
2022-03-08
Results posted
2014-03-05

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT01599741. Inclusion in this directory is not an endorsement.